3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
113
Neoplasm Metastasis
5
Carcinoma, Intraductal, Noninfiltrating
5
Polycystic Ovary Syndrome
4
Ovarian Neoplasms
4
Osteoporosis
4
Neoplasms
4
Infertility
4
Breast Neoplasms, Male
4
Arthralgia
4
Fallopian Tube Neoplasms
3
Triple Negative Breast Neoplasms
2
Pain
2
Leiomyosarcoma
2
Leiomyoma
2
Endometrial Neoplasms
2
Cystadenocarcinoma, Serous
2
Breast Carcinoma In Situ
2
Bone Diseases, Metabolic
2
Advanced Breast Cancer
2
Uterine Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Cysts
1
Osteitis Deformans
1
Obesity
1
Multiple Endocrine Neoplasia Type 1
1
Medullary cystic kidney disease 1
1
Lymphoma, Non-Hodgkin
1
Interventions
Pemetrexed
15
Cisplatin
13
pembrolizumab
6
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cediranib
3
Radiotherapy
3
Gemcitabine
3
Carboplatin
3
amatuximab
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Everolimus
2
Drug Therapy
2
Cyclophosphamide
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tremelimumab
1
sodium thiosulfate
1
sargramostim
1
nintedanib
1
napabucasin
1
methoxyamine
1
liposomal doxorubicin
1
incomplete Freund's adjuvant
1
fresolimumab
1
durvalumab
1
defactinib
1
cixutumumab
1
bintrafusp alfa protein, human
1
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma, Malignant
×
Letrozole
×
Clear all
No trials found.